IRIS
MALAPELLE, UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 10.518
EU - Europa 6.816
NA - Nord America 5.880
SA - Sud America 1.342
AF - Africa 204
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 8
Totale 24.782
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 5.644
US - Stati Uniti d'America 5.592
RU - Federazione Russa 3.484
CN - Cina 2.270
IT - Italia 1.583
HK - Hong Kong 1.166
BR - Brasile 1.108
VN - Vietnam 565
DE - Germania 464
IN - India 296
NL - Olanda 239
FI - Finlandia 200
KR - Corea 192
GB - Regno Unito 188
CA - Canada 135
ES - Italia 108
AR - Argentina 102
IE - Irlanda 101
FR - Francia 100
MX - Messico 96
UA - Ucraina 63
PL - Polonia 54
JP - Giappone 50
BD - Bangladesh 49
ZA - Sudafrica 47
EC - Ecuador 46
CI - Costa d'Avorio 43
AT - Austria 42
ID - Indonesia 41
SE - Svezia 41
TR - Turchia 31
IQ - Iraq 28
PK - Pakistan 27
GR - Grecia 22
VE - Venezuela 22
LT - Lituania 20
EG - Egitto 18
IR - Iran 18
UZ - Uzbekistan 18
CO - Colombia 17
BE - Belgio 16
KE - Kenya 16
MA - Marocco 15
PY - Paraguay 14
SA - Arabia Saudita 14
CH - Svizzera 13
IL - Israele 13
JO - Giordania 13
PE - Perù 13
NP - Nepal 9
RS - Serbia 9
AE - Emirati Arabi Uniti 8
BG - Bulgaria 8
BO - Bolivia 8
CR - Costa Rica 8
CZ - Repubblica Ceca 8
RO - Romania 8
TN - Tunisia 8
AU - Australia 7
MY - Malesia 7
PA - Panama 7
DO - Repubblica Dominicana 6
DZ - Algeria 6
GE - Georgia 6
HN - Honduras 6
HU - Ungheria 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
CL - Cile 5
GA - Gabon 5
UY - Uruguay 5
AL - Albania 4
HR - Croazia 4
KZ - Kazakistan 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
OM - Oman 4
PH - Filippine 4
TW - Taiwan 4
TZ - Tanzania 4
UG - Uganda 4
XK - ???statistics.table.value.countryCode.XK??? 4
BS - Bahamas 3
BW - Botswana 3
DK - Danimarca 3
HT - Haiti 3
KG - Kirghizistan 3
NG - Nigeria 3
NO - Norvegia 3
PS - Palestinian Territory 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AD - Andorra 2
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CV - Capo Verde 2
Totale 24.700
Salva come PNG Salva come JPEG
Città #
Singapore 2.727
Hong Kong 1.146
Hefei 996
Moscow 886
Chandler 681
Ashburn 521
Beijing 510
Naples 301
Santa Clara 264
Los Angeles 215
Ho Chi Minh City 214
Millbury 197
Seoul 187
Munich 173
Milan 168
Kochi 164
Amsterdam 148
Redondo Beach 148
Lawrence 145
Buffalo 138
Des Moines 128
Napoli 123
Boston 116
Hanoi 108
São Paulo 105
Dallas 97
New York 93
The Dalles 86
Rome 79
Helsinki 76
Nanjing 76
Princeton 74
Wilmington 69
Valencia 61
Mexico City 54
Seattle 47
Warsaw 46
Ottawa 43
Nuremberg 41
Turku 41
Chicago 40
Frankfurt am Main 40
Orem 38
Falkenstein 37
Haiphong 35
Boardman 33
Tokyo 33
Atlanta 32
Brooklyn 32
Rio de Janeiro 31
Montreal 30
London 28
Denver 27
Nanchang 27
Chennai 26
Fairfield 25
Houston 25
Poplar 24
Dublin 22
Phoenix 22
Stockholm 22
Da Nang 21
Guangzhou 21
Lappeenranta 21
Toronto 21
Johannesburg 20
Belo Horizonte 19
Bologna 19
Redwood City 19
Hải Dương 18
Curitiba 17
Guayaquil 17
Kronberg 17
Tianjin 17
Düsseldorf 16
Hebei 16
Jacksonville 16
Biên Hòa 15
Buenos Aires 15
Florence 15
Jiaxing 15
Nairobi 15
Porto Alegre 15
Ankara 14
Falls Church 14
Heraklion 14
Manchester 14
Tashkent 14
Woodbridge 14
Amman 13
Brasília 13
Campinas 13
Changsha 13
New Delhi 13
Salt Lake City 13
San Francisco 13
Shanghai 13
Shenyang 13
Thái Nguyên 13
Turin 13
Totale 12.733
Salva come PNG Salva come JPEG
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 179
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing 159
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 156
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients 137
The Cause of Death of a Child in the 18th Century Solved by Bone Microbiome Typing Using Laser Microdissection and Next Generation Sequencing 134
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 132
Liquid biopsy as indication of tumour progression in lung cancer: A potential intervention in tertiary prevention 131
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients 130
Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology? 130
Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer 130
CBX7 is a tumor suppressor in mice and humans. 127
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 125
USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs 125
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 124
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma 124
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 123
Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations. 123
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 118
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. 118
miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene 118
A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers 116
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 116
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 115
Technical evaluation of a novel digital PCR platform for detecting EGFR/KRAS mutations in NSCLC archived plasma specimens 115
Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment 114
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 114
UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status. 113
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives 113
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 113
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study 111
Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models 110
Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study 110
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 110
Endoscopic ultrsound-guided fine needle aspiration (EUS-FNA) in lymph nodal and mediastinal lesions : a multicenter experience 108
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 108
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 108
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 108
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 108
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 107
Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients 106
Antitumor efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models. 106
Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients With Cancer: A Narrative Review 105
In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study 105
Applications and limitations of oncogene mutation testing in clinical cytopathology. 104
Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients 103
Evaluation of a fully closed real time PCR platform for the detection of SARS-CoV-2 in nasopharyngeal swabs: a pilot study 103
Circulating tumor DNA in cancer: Predictive molecular pathology meets mathematics 103
The role of liquid biopsy in epithelial ovarian cancer: state of the art 102
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 101
High-rsolution melting analysis (HRMA) for KRAS mutatiinal study in patients with metastatic colorectal cancer (mCRC pts) 101
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 101
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database 100
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 100
Brca1/2 ngs somatic testing in clinical practice: a short report 100
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories 99
The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience 99
Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx 99
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 99
The evolving role of liquid biopsy in lung cancer 98
Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type 98
Light chains expression of lymphoid infiltrate in fine-needle cytology of Hashimoto thyroiditis. 98
UbcH10 overexpression is less pronounced in older colorectal cancer patients 98
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 98
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 98
Next generation sequencing in cytology 98
Circulating tumor DNA dynamic variation predicts sotorasib efficacy in KRASp.G12C‐mutated advanced non‐small cell lung cancer 98
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 97
Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR 97
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel 97
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 97
Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer 96
Role of Cytomorphology in the Era of Liquid Biopsy 96
A narrative review of lung cancer cytology in the times of coronavirus: What physicians should know 96
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 96
Methods for actionable gene fusion detection in lung cancer: now and in the future 96
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 95
BRAF mutations in lung cancer 95
Mismatch repair proteins and microsatellite instability in solid pseudopapillary neoplasm of the pancreas 95
Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature 94
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE 94
Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy). 94
EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer 94
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 94
Osimertinib 94
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 94
Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study 93
Cytological and Molecular Features of PapillaryThyroid Carcinoma with Prominent Hobnail Features:A Case Report 93
Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates 93
Predictive molecular pathology in the time of COVID-19 93
Preparation of thyroid FNA material for routine cytology and BRAF testing: A validation study. 92
KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy 92
Comparison between two different next generation sequencing platforms for clinical relevant gene mutation test in solid tumours 92
Pharmacodynamics of current and emerging PD-1 and PD-L1 inhibitors for the treatment of non-small cell lung cancer 92
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 92
The evolving role of interventional cytopathology from thyroid FNA to NGS: Lessons learned at Federico II University of Naples 91
Cyclin D1 and D3 overexpression predicts malignant behavior in thyroid fine-needle aspirates suspicious for Hurthle cell neoplasms. 91
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 91
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 91
EGFR mutation detection by microfluidic technology: a validation study. 90
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 90
Totale 10.667
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.714
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021366 0 0 0 0 0 93 22 58 60 57 49 27
2021/20221.155 33 15 24 16 13 23 15 101 103 117 245 450
2022/20231.790 247 87 67 125 230 200 8 201 292 160 142 31
2023/20241.461 62 225 144 64 62 97 56 170 48 77 275 181
2024/20258.774 460 552 45 70 188 328 910 524 736 1.096 3.010 855
2025/202610.760 1.910 1.883 1.912 1.661 2.868 526 0 0 0 0 0 0
Totale 25.339